Mesoblast Plans Small Trial After Second CRL For GVHD Cell Therapy
Executive Summary
Seeking approval for pediatric patients with acute graft-versus-host disease, Mesoblast gets a second US FDA complete response and now says it will seek to get needed data from a small trial in adults.